跳至主要内容
临床试验/IRCT20200825048514N1
IRCT20200825048514N1已完成3 期

The assessment of therapeutic effect of ß-interferon and Methylprednisolone in patients with COVID- 19: A quasi-experimental, double-blind, placebo-controlled study

Yazd University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Age 18- 80 years
  • Covid-19 infection based on high-resolution computed tomography findings
  • Progressive and severe hypoxia based on blood oxygen saturation level less than 88% with a reservoir bag mask and flow of 15 liters
  • Exacerbation of lymphopenia during hospitalization

排除标准

  • Cardiovascular patients
  • Grade 3 and more liver cirrhosis
  • Autoimmune diseases
  • Severe depression and psychosis
  • Organ transplantation
  • Kidney failure

研究者

发起方
Yazd University of Medical Sciences

相似试验